UltraClean GelSpin Kit from Mo Bio Laboratories, Inc.
DNA Fragment 2X Precipitation Solution from EPICENTRE Biotechnologies
DTT, 25g from BioPioneer
AgarPlaque Plus Agarose from BD Biosciences Pharmingen
Biology Products:... issue of G&D , Dr. Fred H. Gage (The Salk Instit...a role for the Hippo signaling pathway in the regu...ng new factors and potential therapeutic targets ...orders and neurological tumor formation. , Their...t on 11/17 at http://genesdev.org . , Establishi...
...struction of new coal-fired power plants in the Un..., partly due to the high cost of the requirement ...issions of carbon dioxide, an important greenhouse... step that could get construction moving again, al...shortages using our most-abundant, least-expensive...
...) A new study by researchers at UC Davis Medical ... of some epilepsy patients may be a result of thei...g seizures. , "Significant drops in blood oxygen ... with partial seizures," said study senior author ...Medical Center and director of the UC Davis Compre...
Other Biology News:New molecular insight into vertebrate brain development 2MIT: A quicker, easier way to make coal cleaner 2MIT: A quicker, easier way to make coal cleaner 3Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 2Drops in blood oxygen levels may be key to sudden death in some epilepsy patients 3(Date:11/20/2009)... , SEATTLE, Nov. 20 D...ed that the U.S. Food and Drug Administration (FDA...y,s amended Biologics License Application (BLA) fo...onse. The FDA has assigned a Prescription Drug Us...ime it will respond to Dendreon,s amended BLA. De...
(Date:11/20/2009)... METTLER TOLEDO recently announ... Process Optimization Using At-Line Particle Chara...2, 2009. In this webinar, the application of in s...ap the design space and optimize a series of rolle...w rates, and roller compaction forces. , ...
(Date:11/19/2009)..., SEATTLE, Nov. 19 Om...unaudited financial results for the third quarter ...ed September 30, 2009, Omeros reported a net loss ...o a net loss of $7.4 million, or $2.54 per share, ...nded September 30, 2009, the Company reported a ne...
(Date:11/19/2009)..., BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/...vator in biotechnology for diabetes therapy, and a...ervices to food, supplement, biotechnology and pha... of Tuesday,s Annual Meeting of Shareholders. ,...ated (Nasdaq: SPEX ) elected the following member...
Breaking Biology Technology:Dendreon Receives FDA Acknowledgement of Complete Response 2Dendreon Receives FDA Acknowledgement of Complete Response 3Roller Compaction Process Optimization Using At-Line Particle Characterization 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Spherix Announces Results of Annual Shareholders Meeting 2Spherix Announces Results of Annual Shareholders Meeting 3Spherix Announces Results of Annual Shareholders Meeting 4